Ginkgo Bioworks Hldgs Inc (DNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,049,244 | 1,105,787 | 1,206,086 | 1,315,792 | 1,302,603 |
| Receivables | 63,143 | 68,918 | 84,841 | 82,465 | 115,756 |
| Inventories | 70 | 391 | 2,509 | N/A | 5,860 |
| TOTAL | $1,141,846 | $1,223,453 | $1,327,306 | $1,450,079 | $1,462,003 |
| Non-Current Assets | |||||
| PPE Net | 201,595 | 294,244 | 313,973 | 314,773 | 187,577 |
| Investments And Advances | 86,090 | 121,064 | 122,937 | 113,731 | 100,445 |
| Intangibles | 158,225 | 163,862 | 167,461 | 171,251 | 76,742 |
| Other Non-Current Assets | 438,636 | 489,376 | 485,532 | 489,487 | 43,928 |
| TOTAL | $884,546 | $1,068,546 | $1,089,903 | $1,089,242 | $408,692 |
| Total Assets | $2,026,392 | $2,291,999 | $2,417,209 | $2,539,321 | $1,870,695 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 10,753 | 13,630 | 21,571 | 10,451 | 11,323 |
| Accrued Expenses | 114,947 | 110,478 | 122,615 | 114,694 | 72,990 |
| TOTAL | $168,462 | $163,331 | $191,704 | $172,962 | $124,818 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 42,762 | 39,223 | 47,518 | 47,817 | 40,505 |
| Other Non-Current Liabilities | 435,236 | 445,180 | 443,104 | 452,925 | 74,661 |
| TOTAL | $605,247 | $625,083 | $617,919 | $630,082 | $306,141 |
| Total Liabilities | $773,709 | $788,414 | $809,623 | $803,044 | $430,959 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 52,961 | 49,471 | 49,137 | 48,815 | 43,500 |
| Common Shares | 198 | 196 | 194 | 190 | 165 |
| Retained earnings | -5,078,834 | -4,775,943 | -4,602,628 | -4,397,659 | -4,226,310 |
| Other shareholders' equity | -2,899 | -1,300 | -1,614 | -2,632 | -2,910 |
| TOTAL | $1,252,683 | $1,503,585 | $1,607,586 | $1,736,277 | $1,439,736 |
| Total Liabilities And Equity | $2,026,392 | $2,291,999 | $2,417,209 | $2,539,321 | $1,870,695 |